Genzyme’s oral treatment for Gaucher - Cerdelga (eliglustat)
Quite easy to do a lot better than a poor drug like Zavesca :) Seriously, the way data look so far, I think Cerdelga will take a major market share (more than 50%) from ERTs in few years time. Perhaps the war might also be another reason why PLX is so beaten lately.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.